Back to top

LACOG 0618

  /    /  LACOG 0618

Safety and Efficacy of Nivolumab in previously treated patients with advanced NSCLC: Real World Data from an Expanded Access Program in Brazil

Type of Study: Clinical Trial

Sponsor / Support: LACOG, GBOT

Primary Objectives: Evaluate safety and efficacy of Nivolumab in a Brazilian population

Design: This is a retrospective analysis of the cohort of patients who participated in the CA 209-169 Expanded Access Program and were treated in Brazilian institutions.

Sample Size: 108 patients

Principal Investigator: Ana Caroline Zimmer Gelatti

Countries LATAM: Brazil